Alexander O. Schuth is COO & Secretary at Denali Therapeutics Inc. (DNLI). They have made 50 open-market trades across 1 company since 2018, most recently 2026-09-01.
CIK 0001724311
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 50 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| DNLI | 278,995 | $4.9M |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| DNLI | SELL · 10b5-1 | 2026-09-01 | 2026-09-03 | $23.44 | $65K | -10.6% | -11.2% | — |
| DNLI | SELL | 2026-08-11 | 2026-08-13 | $25.07 | $72K | +1.5% | -13.7% | — |
| DNLI | SELL | 2026-01-06 | 2026-01-08 | $16.50 | $284K | +7.0% | +19.8% | +12.9% |
| DNLI | SELL | 2025-08-12 | 2025-08-14 | $13.58 | $40K | +6.7% | -9.7% | +20.2% |
| DNLI | SELL | 2025-01-06 | 2025-01-08 | $20.33 | $617K | +13.9% | +8.7% | -43.9% |
| DNLI | SELL · 10b5-1 | 2024-11-07 | 2024-11-12 | $29.81 | $831K | -17.8% | -21.9% | -30.5% |
| DNLI | SELL · 10b5-1 | 2024-08-20 | 2024-08-22 | $23.99 | $401K | +4.4% | +25.4% | +1.3% |
| DNLI | SELL | 2024-08-13 | 2024-08-15 | $22.89 | $104K | +6.0% | +28.8% | +25.8% |
| DNLI | SELL · 10b5-1 | 2024-02-13 | 2024-02-15 | $17.64 | $758K | +13.7% | +13.0% | +17.3% |
| DNLI | SELL | 2024-01-05 | 2024-01-09 | $19.43 | $388K | -11.2% | -11.8% | -2.4% |
| DNLI | SELL | 2023-08-23 | 2023-08-25 | $23.17 | $117K | +5.2% | -4.3% | -19.9% |
| DNLI | SELL | 2023-08-21 | 2023-08-23 | $22.59 | $112K | +4.5% | -2.9% | -20.2% |
| DNLI | SELL | 2023-08-14 | 2023-08-16 | $23.67 | $131K | -3.1% | +0.2% | -18.6% |
| DNLI | SELL | 2023-08-10 | 2023-08-14 | $24.18 | $138K | -7.5% | -1.0% | -32.9% |
| DNLI | SELL | 2023-07-17 | 2023-07-19 | $29.87 | $878K | -5.3% | -24.8% | -31.5% |
| DNLI | SELL | 2023-05-15 | 2023-05-17 | $28.60 | $286K | -1.3% | +4.7% | -18.1% |
| DNLI | SELL | 2023-04-12 | 2023-04-14 | $25.04 | $501K | -1.7% | +29.1% | +18.3% |
| DNLI | SELL | 2023-02-13 | 2023-02-15 | $30.09 | $210K | -8.7% | -21.6% | -1.5% |
| DNLI | SELL | 2023-02-08 | 2023-02-10 | $30.89 | $47K | -8.1% | -19.5% | -4.9% |
| DNLI | SELL | 2023-01-17 | 2023-01-19 | $29.53 | $587K | +2.2% | -3.0% | -15.7% |
| DNLI | SELL | 2023-01-05 | 2023-01-09 | $28.44 | $150K | +5.6% | +10.7% | -12.6% |
| DNLI | SELL | 2023-01-04 | 2023-01-09 | $28.70 | $167K | +5.6% | +10.7% | -12.6% |
| DNLI | SELL | 2022-08-19 | 2022-08-23 | $33.22 | $171K | -13.4% | -15.2% | -8.6% |
| DNLI | SELL | 2022-02-11 | 2022-02-15 | $34.68 | $194K | -7.6% | -7.3% | -34.0% |
| DNLI | SELL | 2022-02-09 | 2022-02-11 | $37.10 | $106K | -5.5% | -16.8% | -37.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.